HeartSciences Files Fortitude Interim Financials Showing $14.2M Loss and $10.3M Impairment
HSCS sits 53% above its 52-week low of $1.63 on light trading volume (0.1× avg).
Summary
HeartSciences filed Fortitude's interim financials showing a $14.2M net loss and $10.3M impairment, plus subsequent events including a $1,000 private placement and weather-related losses.
Key Events · M&A and Partnerships · HSCS
-
Fortitude Interim Loss
Fortitude reported a net loss of $14.2 million for the six months ended June 30, 2026, compared to a $13.7 million loss in the prior year period.
-
Mining Equipment Impairment
Fortitude recorded a $10.3 million impairment charge on Bitcoin and other non-Zcash mining equipment due to sustained declines in digital asset prices and mining hashprice.
-
Related-Party Credit Draw
Fortitude drew $5.2 million under a $26 million credit facility with parent DCG, with an outstanding balance of $14.7 million as of the filing date.
-
Private Placement
On August 12, 2026, Fortitude agreed to purchase 411,522 shares of HeartSciences common stock at $2.43 per share for $1,000 in a private placement.
Analysis · HSCS · Crypto Assets
The filing provides Fortitude's unaudited interim financials for the six months ended June 30, 2026, revealing a net loss of $14.2 million, a $10.3 million impairment on Bitcoin mining equipment, and a $5.2 million draw on a related-party credit facility. It also discloses subsequent events including a $1,000 private placement of HeartSciences shares at $2.43 per share and a weather-related incident causing estimated losses under $2.2 million. These details are material to the pending merger, as they show Fortitude's financial strain and operational challenges.
At the time of this filing, HSCS was trading at $2.50 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $9.9M. The 52-week trading range was $1.63 to $3.93. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.